Nippon Life Insurance Co. held its stake in shares of Lam Research Co. (NASDAQ:LRCX) during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,272 shares of the semiconductor company’s stock at the end of the first quarter. Nippon Life Insurance Co.’s holdings in Lam Research were worth $1,832,000 as of its most recent filing with the SEC.
Other large investors also recently made changes to their positions in the company. Norges Bank bought a new stake in shares of Lam Research during the fourth quarter worth $138,959,000. Janus Capital Management LLC raised its stake in Lam Research by 24.3% in the fourth quarter. Janus Capital Management LLC now owns 3,175,155 shares of the semiconductor company’s stock valued at $335,710,000 after buying an additional 621,245 shares during the last quarter. Capital Growth Management LP acquired a new stake in Lam Research during the third quarter valued at approximately $50,196,000. Pioneer Investment Management Inc. raised its stake in Lam Research by 141.6% in the third quarter. Pioneer Investment Management Inc. now owns 793,249 shares of the semiconductor company’s stock valued at $75,129,000 after buying an additional 464,963 shares during the last quarter. Finally, Westwood Holdings Group Inc. acquired a new stake in Lam Research during the fourth quarter valued at approximately $43,783,000.
Lam Research Co. (NASDAQ:LRCX) traded up 0.44% on Friday, hitting $139.98. 3,260,122 shares of the stock traded hands. The firm has a 50-day moving average price of $125.74 and a 200-day moving average price of $111.36. Lam Research Co. has a 12 month low of $72.00 and a 12 month high of $140.23. The company has a market capitalization of $22.79 billion, a PE ratio of 25.09 and a beta of 1.44.
Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Tuesday, April 18th. The semiconductor company reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.55 by $0.25. Lam Research had a net margin of 15.67% and a return on equity of 19.95%. The company earned $2.15 billion during the quarter, compared to analyst estimates of $2.13 billion. During the same period last year, the firm posted $1.18 EPS. Lam Research’s revenue for the quarter was up 63.9% compared to the same quarter last year. Analysts forecast that Lam Research Co. will post $9.27 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, March 29th. Stockholders of record on Wednesday, March 8th were issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 1.29%. The ex-dividend date of this dividend was Monday, March 6th. Lam Research’s dividend payout ratio (DPR) is 32.37%.
TRADEMARK VIOLATION WARNING: “Lam Research Co. (LRCX) Position Maintained by Nippon Life Insurance Co.” was originally posted by BBNS and is the property of of BBNS. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://baseballnewssource.com/markets/lam-research-co-lrcx-position-maintained-by-nippon-life-insurance-co/638164.html.
LRCX has been the topic of several research reports. Zacks Investment Research raised shares of Lam Research from a “hold” rating to a “buy” rating and set a $121.00 price objective on the stock in a research note on Monday, January 16th. Royal Bank of Canada reissued an “outperform” rating and set a $145.00 price objective (up previously from $140.00) on shares of Lam Research in a research note on Tuesday. Needham & Company LLC reissued a “buy” rating and set a $145.00 price objective (up previously from $135.00) on shares of Lam Research in a research note on Thursday, January 26th. Summit Redstone reissued a “buy” rating on shares of Lam Research in a research note on Saturday, January 21st. Finally, Stifel Nicolaus reissued a “buy” rating and set a $150.00 price objective on shares of Lam Research in a research note on Monday. Two investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $127.56.
In other news, insider Patrick J. Lord sold 1,383 shares of Lam Research stock in a transaction that occurred on Monday, February 13th. The shares were sold at an average price of $117.02, for a total transaction of $161,838.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Timothy Archer sold 4,223 shares of Lam Research stock in a transaction that occurred on Thursday, March 23rd. The shares were sold at an average price of $125.25, for a total transaction of $528,930.75. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 265,968 shares of company stock valued at $31,900,341. Insiders own 0.46% of the company’s stock.
Lam Research Company Profile
Lam Research Corporation is a supplier of wafer fabrication equipment and services to the semiconductor industry. The Company designs, manufactures, markets, refurbishes and services semiconductor processing systems that are used in the fabrication of integrated circuits (ICs). It operates through manufacturing and servicing of wafer processing semiconductor manufacturing equipment segment.
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX).
Receive News & Ratings for Lam Research Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research Co. and related companies with our FREE daily email newsletter.